[Thrombocyte IIb/IIIa receptor inhibitors--a new direction in antithrombotic therapy].
Panchenko
E P
EP
D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D015912:Thrombolytic Therapy / Q000639:trends*
D005343:Fibrinolytic Agents; D019039:Platelet Glycoprotein GPIIb-IIIa Complex